BARBANTI, MARCO
 Distribuzione geografica
Continente #
AS - Asia 9.789
NA - Nord America 9.398
EU - Europa 8.306
SA - Sud America 930
AF - Africa 63
OC - Oceania 10
Totale 28.496
Nazione #
US - Stati Uniti d'America 9.293
HK - Hong Kong 7.851
IE - Irlanda 5.955
SG - Singapore 1.398
GB - Regno Unito 905
BR - Brasile 846
CH - Svizzera 405
FI - Finlandia 319
IT - Italia 222
DE - Germania 203
TR - Turchia 132
CN - Cina 104
CA - Canada 57
FR - Francia 55
IN - India 46
BD - Bangladesh 44
EE - Estonia 40
VN - Vietnam 39
MX - Messico 36
CZ - Repubblica Ceca 35
NL - Olanda 35
AR - Argentina 30
PL - Polonia 27
KR - Corea 25
RU - Federazione Russa 24
ZA - Sudafrica 24
EC - Ecuador 19
IQ - Iraq 19
UZ - Uzbekistan 19
JP - Giappone 18
SE - Svezia 17
PK - Pakistan 16
AT - Austria 14
ES - Italia 14
IR - Iran 11
UA - Ucraina 11
EG - Egitto 10
AU - Australia 9
MA - Marocco 9
IL - Israele 8
TW - Taiwan 8
VE - Venezuela 8
CO - Colombia 7
KE - Kenya 7
CL - Cile 6
LT - Lituania 6
SA - Arabia Saudita 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
NP - Nepal 5
BG - Bulgaria 4
ET - Etiopia 4
ID - Indonesia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
AZ - Azerbaigian 3
BE - Belgio 3
LV - Lettonia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
JM - Giamaica 2
LB - Libano 2
PS - Palestinian Territory 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 28.496
Città #
Hong Kong 7.850
Dublin 5.918
Dallas 4.608
Ashburn 855
London 832
Boardman 807
Santa Clara 432
Singapore 420
Zurich 405
Helsinki 309
The Dalles 274
Washington 197
Istanbul 110
Los Angeles 98
Assago 76
Munich 72
São Paulo 70
Chicago 40
San Francisco 39
New York 32
Rio de Janeiro 27
Brooklyn 26
Council Bluffs 26
Seattle 26
Seoul 25
Belo Horizonte 24
Frankfurt am Main 24
Milan 24
Montreal 23
Warsaw 22
Brno 21
Amsterdam 17
Stockholm 17
Boston 16
Brasília 16
Johannesburg 16
Mexico City 16
Tashkent 16
Atlanta 15
Ho Chi Minh City 15
Catania 14
Olomouc 14
Porto Alegre 14
Shanghai 14
Tokyo 13
Falkenstein 12
Chennai 11
Curitiba 11
Salvador 11
Cipolletti 10
Duque de Caxias 10
Rome 10
Bexley 9
Clifton 9
Düsseldorf 9
Hanoi 9
Phoenix 9
Piscataway 9
Turku 9
Fortaleza 8
Guangzhou 8
Manchester 8
Tanta 8
Tappahannock 8
Columbus 7
Dhaka 7
Genoa 7
Goiânia 7
Guarulhos 7
Guayaquil 7
Nairobi 7
Ottawa 7
Ankara 6
Campinas 6
Canoas 6
Karachi 6
Quito 6
San Jose 6
Toronto 6
Turin 6
Amman 5
Bauru 5
Contagem 5
Denver 5
Joinville 5
Lauterbourg 5
Manaus 5
Montevideo 5
Mumbai 5
Naples 5
Osasco 5
Ribeirão Preto 5
Roubaix 5
Sumaré 5
São José dos Campos 5
Addis Ababa 4
Bogotá 4
Bragança Paulista 4
Buenos Aires 4
Cariacica 4
Totale 24.302
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 1.312
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.163
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 956
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 951
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 707
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 637
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 552
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 505
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 487
Predicting neocommissural orientation during TAVI workup 484
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 423
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 369
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 367
Le nuove frontiere della cardiologia interventistica strutturale 350
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 135
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 116
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 110
Transcatheter mitral valve implantation: CardiAQ 109
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 109
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 103
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 102
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 101
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 99
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 96
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 95
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 95
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 94
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 93
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 93
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 92
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 92
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 91
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 91
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 90
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 87
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 84
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 82
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 82
Managing complications after transcatheter aortic valve implantation 80
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 80
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 80
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 79
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 79
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 78
Early detection of transcatheter heart valve dysfunction 77
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 76
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 76
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 76
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 75
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 75
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 74
The Helio transcatheter aortic dock for patients with aortic regurgitation 74
Cerebral embolization during transcatheter aortic valve implantation 74
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 74
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 74
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 74
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 74
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 73
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 73
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 72
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 71
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 71
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 70
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 70
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 70
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 70
Bioprosthetic valves for transcatheter aortic valve replacement 70
Management of severe stenosis controversies and promises 70
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 70
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 69
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 68
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 68
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 67
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 67
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 67
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 67
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 67
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 67
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 67
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 67
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 67
Transcatheter mitral valve repair: a brief review 66
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 66
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 66
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 66
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 66
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 66
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 66
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 66
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 66
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 66
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 66
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 66
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 65
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 65
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 65
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 65
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 65
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 65
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 64
Totale 15.957
Categoria #
all - tutte 130.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/20265.699 870 3.391 1.438 0 0 0 0 0 0 0 0 0
Totale 28.924